EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Acquired hemophilia A following choledochal cyst excision - highlighting postoperative bile leak and infection as potential triggers: A case report

Shun-Rong Yuan, Li Cao, Xiao-Ju Li, Yong Cao

World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)

DOI: 10.4240/wjgs.125182 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Acquired hemophilia A (AHA) is a rare and potentially fatal bleeding disorder mediated by autoantibodies against coagulation factor VIII (FVIII). Its nonspecific clinical presentation often leads to delayed diagnosis and life-threatening complications. Early recognition and standardized management are crucial for improving outcomes. Secondary AHA following choledochal cyst excision is extremely rare, with no prior reports in the literature. This case report explored the possible etiology, treatment strategies, and disease course of AHA in a patient. CASE SUMMARY A 37-year-old woman developed postoperative bile leakage, infection, and recurrent bleeding after laparoscopic choledochal cyst excision with Roux-en-Y hepaticojejunostomy, which was subsequently complicated by AHA. On postoperative day 6, she presented with intra-abdominal hemorrhage. Despite repeated interventions, including exploratory laparotomy and interventional embolization, intermittent active bleeding remained uncontrolled. After multidisciplinary team consultation, she was finally diagnosed with AHA. Treatment included infection control, combined immunosuppressive therapy with corticosteroids and cyclophosphamide, seven plasma exchange sessions, and FVIII replacement therapy. Bleeding was effectively controlled, the intra-abdominal abscess healed, and the patient was discharged after clinical remission was achieved. At the 6-month follow-up, no signs of recurrent bleeding were noted. CONCLUSION Prompt FVIII activity and inhibitor testing, along with comprehensive treatment, should be implemented in patients suspicious for AHA.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →